A descriptive study based on the secondary analysis of the Unique System of Information database, Subsystem 13 of Hospital discharges to oral cancer of the Mexican Institute of Social Security (IMSS) during the decade from 1991 to 2000, it was considered all the registrations for oral cancer according to the International Classification of Diseases ICD-9. During that time, 8,800 hospital discharges were registered for oral cancer, out of which 64.6% (n = 5682) were men. The men: women ratio showed 1.8 men per admitted woman for oral cancer. The mortality gross rate for oral cancer was of 50.4 for each 100,000 hospital discharges with a significantly descendent trend. Hospital discharges rate by age group was specifically concentrated in population to 35 years-old or more, registering themselves the greater rates as of the 55 years-old. The hospital average stay was of 5.1 days. According to the topography of the oral cavity, we found that the tongue (25.1%), principal salivary glands (24.0%) and tonsil-oropharynx (14.2%) were the main places where this pathology presented. During the above decade, the oral cancer hospital discharges registered in the IMSS didn't show an increasing pattern.

Download full-text PDF

Source

Publication Analysis

Top Keywords

oral cancer
28
hospital discharges
20
oral
8
discharges oral
8
cancer mexican
8
mexican institute
8
institute social
8
social security
8
discharges registered
8
cancer
7

Similar Publications

TRAIL agonists rescue mice from radiation-induced lung, skin or esophageal injury.

J Clin Invest

January 2025

Laboratory of Translational Oncology and Translational Cancer Therapeutics, Warren Alpert Medical School of Brown University, Providence, United States of America.

Radiotherapy can be limited by pneumonitis which is impacted by innate immunity, including pathways regulated by TRAIL death receptor DR5. We investigated whether DR5 agonists could rescue mice from toxic effects of radiation and found two different agonists, parenteral PEGylated trimeric-TRAIL (TLY012) and oral TRAIL-Inducing Compound (TIC10/ONC201) could reduce pneumonitis, alveolar-wall thickness, and oxygen desaturation. Lung protection extended to late effects of radiation including less fibrosis at 22-weeks in TLY012-rescued survivors versus un-rescued surviving irradiated-mice.

View Article and Find Full Text PDF

MircoRNAs predict and modulate responses to chemotherapy in leukemic patients.

Naunyn Schmiedebergs Arch Pharmacol

January 2025

Oral Biology Department, Faculty of Dentistry, Galala Plateau, Galala University, 15888), Attaka, Suez Governorate, Egypt.

Leukemia covers a broad category of cancer malignancies that specifically affect bone marrow and blood cells. While different kinds of leukemia have been identified, effective treatments are still lacking for most forms, and even those treatments considered effective can lead to relapses. MicroRNAs, or miRNAs, are short endogenous non-coding single-stranded RNAs that help control the epigenetics of gene expression.

View Article and Find Full Text PDF

Machine learning prediction model for oral mucositis risk in head and neck radiotherapy: a preliminary study.

Support Care Cancer

January 2025

Oral Diagnosis Department, Faculdade de Odontolodia de Piracicaba, Universidade de Campinas (UNICAMP), Piracicaba, São Paulo, Brazil.

Purpose: Oral mucositis (OM) reflects a complex interplay of several risk factors. Machine learning (ML) is a promising frontier in science, capable of processing dense information. This study aims to assess the performance of ML in predicting OM risk in patients undergoing head and neck radiotherapy.

View Article and Find Full Text PDF

Association between hormone therapy and glioma risk in US women: a cancer screening trial.

Menopause

January 2025

From the Department of Neurosurgery, Chongqing General Hospital, Chongqing University, Chongqing, China.

Objective: Gliomas are the most common primary brain tumors in adults, and the role of hormone therapy (HT) in their development remains controversial. This study with a cohort design aimed to investigate the association between HT use and glioma risk using the data from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.

Methods: We analyzed data from 75,335 women, aged 50-78, who were enrolled between 1993 and 2001.

View Article and Find Full Text PDF

Introduction: Pathway-driven, post-pancreatectomy opioid reduction interventions have proven effective and sustainable and may have a "halo effect" on other major abdominal cancer operations. This study's aim was to analyze the sequential effects of expanding opioid reduction efforts from pancreatectomy on opioids prescribed after hepatectomy.

Methods: This is a retrospective cohort study utilizing data from the electronic health record and a prospective quality improvement database for consecutive hepatectomy patients (09/2016-02/2024).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!